Learn more about Market Access

Market Access

Pharmaceutical Market Access: Reach New Markets More Effectively

You’re measured on how well your products achieve the most favorable market acceptance and adoption. This means you seek to:

  • Understand your worldwide pharmaceutical, biotechnology, and medical device market access and increase its potential
  • Prove value and win preferred position on formularies
  • Identify the correct payor messaging

Quintiles offers you insight into pharmaceutical, biotechnology, and medical device markets worldwide through our vast clinical and commercialization knowledge base. This service and industry breadth also enables us to provide you realistic guidance on tackling complex cross-over and emerging areas, such as evidence-based medicine.

Our consultants’ astute analytical skills as well as a deep understanding of payers’ requirements mean we can provide you practical advice on making your pharmaceutical, biotechnology and medical device market access programs efficient and effective. Our services range from health technology assessments to forecasting, cost-based valuation to outcomes analysis.

Contact Us

Consulting Services

+44 (0) 1344 601189
US: +1 877 988 2100

External Validity and Convergence - NextLevel Pharma - June 2010

Slides from Jacco Keja’s in-conference workshop at NextLevel 2010 conference – Clinical Trail Design to Demonstrate Health Outcomes and maximize Access Potential

View now

White Paper

Rewarding Innovation and Value: What is the Role of Comparative Effectiveness Research

The impact of comparative effectiveness research on the future of drug development.

Read more

Case Study

Accessing the Business Impact of Comparative Effectiveness

The increasing use of Health Technology Assessments (HTA) is emerging as a policy issue that could have significant effects on every link in the product development chain.

Learn more

John Doyle, Dr. PH

Practice Leader

Read more